IN2014MN01546A - - Google Patents
Info
- Publication number
- IN2014MN01546A IN2014MN01546A IN1546MUN2014A IN2014MN01546A IN 2014MN01546 A IN2014MN01546 A IN 2014MN01546A IN 1546MUN2014 A IN1546MUN2014 A IN 1546MUN2014A IN 2014MN01546 A IN2014MN01546 A IN 2014MN01546A
- Authority
- IN
- India
- Prior art keywords
- compounds
- formula
- diastereoisomers
- stereoisomers
- prevention
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 2
- 150000002212 flavone derivatives Chemical group 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 208000003265 stomatitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261586428P | 2012-01-13 | 2012-01-13 | |
| PCT/IB2013/050263 WO2013105056A1 (en) | 2012-01-13 | 2013-01-11 | Pyrrolidine- substituted flavone derivatives for prevention or treatment of oral mucositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01546A true IN2014MN01546A (enrdf_load_stackoverflow) | 2015-05-08 |
Family
ID=47748672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1546MUN2014 IN2014MN01546A (enrdf_load_stackoverflow) | 2012-01-13 | 2013-01-11 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20140348950A1 (enrdf_load_stackoverflow) |
| EP (1) | EP2802323B1 (enrdf_load_stackoverflow) |
| AR (1) | AR090052A1 (enrdf_load_stackoverflow) |
| IN (1) | IN2014MN01546A (enrdf_load_stackoverflow) |
| TW (1) | TW201338774A (enrdf_load_stackoverflow) |
| WO (1) | WO2013105056A1 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI839690B (zh) | 2013-07-12 | 2024-04-21 | 印度商皮拉馬爾企業有限公司 | 治療黑色素瘤的藥物組合的用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7884127B2 (en) | 2002-07-08 | 2011-02-08 | Pirimal Life Sciences Ltd. | Inhibitors of cyclin dependent kinases and their use |
| TWI331034B (en) | 2002-07-08 | 2010-10-01 | Piramal Life Sciences Ltd | Inhibitors of cyclin-dependent kinases and their use |
| PT2046738E (pt) | 2006-06-21 | 2014-08-29 | Piramal Entpr Ltd | Derivados de flavona enantiomericamente puros para o tratamento de distúrbios proliferativos e processos para a sua preparação |
| AU2006346193C1 (en) | 2006-07-07 | 2014-02-20 | Piramal Enterprises Limited | An enantioselective synthesis of pyrrolidine-substituted flavones |
| TWI461194B (zh) * | 2009-05-05 | 2014-11-21 | Piramal Entpr Ltd | 吡咯啶取代黃酮作為輻射致敏劑 |
-
2013
- 2013-01-11 IN IN1546MUN2014 patent/IN2014MN01546A/en unknown
- 2013-01-11 WO PCT/IB2013/050263 patent/WO2013105056A1/en active Application Filing
- 2013-01-11 TW TW102101025A patent/TW201338774A/zh unknown
- 2013-01-11 US US14/371,145 patent/US20140348950A1/en not_active Abandoned
- 2013-01-11 EP EP13705838.4A patent/EP2802323B1/en not_active Not-in-force
- 2013-01-14 AR ARP130100106A patent/AR090052A1/es unknown
-
2016
- 2016-07-18 US US15/213,304 patent/US20170071908A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW201338774A (zh) | 2013-10-01 |
| US20170071908A1 (en) | 2017-03-16 |
| US20140348950A1 (en) | 2014-11-27 |
| EP2802323B1 (en) | 2016-08-10 |
| EP2802323A1 (en) | 2014-11-19 |
| AR090052A1 (es) | 2014-10-15 |
| WO2013105056A1 (en) | 2013-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202003554B (en) | 1 -(piperidinocarbonylmethyl)-2-oxopiperazine derivatives for treating cancer | |
| MX2014009757A (es) | Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia. | |
| NZ708593A (en) | Novel pyrazole derivative | |
| GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
| PH12016502355B1 (en) | Pharmaceutical composition | |
| MX2011008634A (es) | Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia. | |
| UA109698C2 (xx) | Похідні азаіндазолу або діазаіндазолу як медикамент | |
| BR112015001502A2 (pt) | derivados de tipo azaindazol ou diazaindazol para tratamento de dor | |
| PH12014502605A1 (en) | Uracyl spirooxetane nucleosides | |
| NZ708382A (en) | Cycloalkyl bis-thiadiazole inhibitors of glutaminase and their use as therapeutic agents | |
| PH12015502159A1 (en) | Chemical entities | |
| MX345238B (es) | (aralquilamino y heteroarilalquilamino alfa-substituidos)pirimidin ilo y 1,3,5-triazinilbenzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para su uso en el tratamiento de enfermedades proliferativas. | |
| PH12014500386A1 (en) | Combination treatment for hepatitis c | |
| MX369952B (es) | Derivados de 1,4-dihidrodioxina fusionada como inhibidores del factor de transcripción de choque térmico 1. | |
| EA201001196A1 (ru) | Соединения 4-пиридинона и их применение для лечения рака | |
| PH12016502353A1 (en) | Pharmaceutical composition | |
| MX2015011614A (es) | Derivados de pirrolidina, composiciones farmaceuticas que los contienen, y su uso en terapia. | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| MX362896B (es) | Cis-morfolinona y otros compuestos como inhibidores de mdm2 para el tratamiento del cáncer. | |
| MX2022000390A (es) | Derivados macrociclicos espirociclicos como inhibidores de mcl-1. | |
| BR112017005242A2 (pt) | composto, composição farmacêutica, e, composto para uso. | |
| TR201819805T4 (tr) | Flavaglin türevleri̇. | |
| MX2022006179A (es) | Derivados macrociclicos de indol como inhibidores de mcl-1. | |
| MX2015009176A (es) | Derivados de triazola antivirales. | |
| IN2014MN01546A (enrdf_load_stackoverflow) |